Progeria: A Rare Genetic Syndrome
- 25 September 2019
- journal article
- review article
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 35 (1) , 3-7
Abstract
An uncommon deadly genetic situation symbolized by the presence of rapid maturation in infants is called as the Hutchinson–Gilford Progeria Syndrome. The term basically is meant as ‘prematurely old’ taken from the Greek meanings. The selective cause behind this syndrome is usually a mutation in a gene called LMNA. The product of this LMNA gene which is a protein i.e. Lamin-A is considered to be responsible for anatomical framing which clasps the nuclei of the cell, well organized and together. But, the recent investigations prove a deformity in the protein i.e. Lamin-A that leads to the non-stability of the nuclei an thus gives rise to the deadly situation of untimely ageing in the children popularly known as Progeria. The literature review investigation provided pivotal information about the therapeutic researches related to the syndrome, the mutational causes and the basic information including the major and minor symptoms generally shown by the patients affected with Hutchinson–Gilford Progeria Syndrome. Investigations on this rare, uncommon disease i.e. Progeria had begun a couple of years back and in some of the researches many important aspects about the causes and possible curative drugs related to the disease which can help the patients in leading a normal life with lesser side effects and symptoms have also been discussed. Further studies will more clearly clarify the possible curative agents and unrevealed mechanisms of the disease which will help the scientists to develop measures which can provide more beneficial and healthy life to the patients with lesser complications.Keywords
This publication has 24 references indexed in Scilit:
- Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylationCell Death & Disease, 2016
- Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasionNature Communications, 2013
- Farnesyltransferase inhibitor treatment restores chromosome territory positions and active chromosome dynamics in Hutchinson-Gilford progeria syndrome cellsGenome Biology, 2011
- The Defective Nuclear Lamina in Hutchinson-Gilford Progeria Syndrome Disrupts the Nucleocytoplasmic Ran Gradient and Inhibits Nuclear Localization of Ubc9Molecular and Cellular Biology, 2011
- Lamin A precursor induces barrier-to-autointegration factor nuclear localizationCell Cycle, 2010
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- HGPS and related premature aging disorders: From genomic identification to the first therapeutic approachesMechanisms of Ageing and Development, 2008
- An association of Hutchinson–Gilford progeria and malignancyAmerican Journal of Medical Genetics Part A, 2007
- Farnesyltransferase inhibitors2005
- Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndromeNature, 2003